Skip to main content

Life Technologies Enters Alliance with Luxembourg Biobank

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Life Technologies has inked an agreement with the Integrated Biobank of Luxembourg under which it will use Life Technologies' Applied Biosystems SOLiD System to sequence its biospecimen samples.

The IBBL is an independent, non-profit biobanking and biotech foundation that has focused initially on collecting, storing, analyzing, and distributing cancer biospecimen samples. It was co-founded in 2008 by Luxembourg's three public research centers — CRP-Santé, CRP-Henri Tudor, CRP-Gabriel Lippmann — the University of Luxembourg, and Arizona's Translational Genomics Research Institute.

Life Technologies said that the collaboration could result in a greater understanding of the genetic basis for many diseases and could eventually have application in using sequencing for clinical diagnostics.

"By partnering with Life Technologies, IBBL is gaining access to cutting-edge sequencing technology, an important step to building an advanced technology infrastructure and a successful biomedical research industry in Luxembourg," Jean-Claude Schmit, president of IBBL, said in a statement.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.